PHARMACIA UPJOHN
PharmaPHARMACIA UPJOHN is a pharmaceutical company focused on Immunology, Gastroenterology.
PHARMACIA UPJOHN's Key Drugs
PHARMACIA UPJOHN's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PHARMACIA UPJOHN's Recent FDA Approvals
New NDA/BLA approvals for PHARMACIA UPJOHN over the last two years — novel drugs only, excluding generics and label supplements.
PHARMACIA UPJOHN's Therapeutic Areas
PHARMACIA UPJOHN's approved drugs and pipeline span 2 therapeutic areas, led by Immunology and Gastroenterology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PHARMACIA UPJOHN's Top Competitors
PHARMACIA UPJOHN's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PHARMACIA UPJOHN Pipeline Snapshot
Active clinical trials for PHARMACIA UPJOHN across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2000-08-18
- Latest
- 2000-08-18
- Applications
- 1